Yi Zhao

Company: Sino-Cell Biomed New!

Job title: Chief Technology Officer & Chief Executive Officer

Seminars:

Optimizing Manufacture Culture Conditions to Reduce Dependence on IL2 In Vivo 4:30 pm

Reduced IL-2 in culture system Target production time 16 days Significantly less IL-2 after TIL infusion and TCR data show TIL repopulation in vivoRead more

day: Conference Day One